Subscribe
type here...
Subscribe

Drug Development

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Drug Development Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September 1 and will expire on...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Global Markets Techno -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta vaccine candidate. Sanofi-GSK’s vaccine is...
spot_imgspot_img

GSK comes close to creating a hard-to-reach RSV vaccine

Drug Development Techno -
GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim...

Code Biotherapeutics raises $75 Million to advance programs to treat and cure rare and prevalent genetic diseases

Drug Development Techno -
Code Biotherapeutics, Inc., (Code Bio), a biotechnology company pioneering targeted non-viral delivery of genetic medicines, today announced its upsized...

Emmes launches Advantage eClinical as a stand-alone cloud-based clinical platform

Drug Development Techno -
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is...

Open Orphan signs a £7.3 million contract for influenza human challenge study

Drug Development Techno -
Open Orphan PLC said Wednesday that its hVIVO subsidiary has signed a 7.3 million pounds ($9.1 million) influenza human...

Startup RQ Biotechnology received $157 million from AstraZeneca for Covid antibodies

Global Markets Techno -
RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of...

MicroGEM’s PCR test, which gives results in 27 minutes, received EUA approval from FDA

Regulatory Techno -
MicroGEM has been granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the MicroGEM...
Load more

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

0
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Russia Updates Pharma Licensing: New Timelines and Remote Inspections

0
The Russian Government has approved a new resolution updating...

GMP-Inspections of veterinary manufacturers in July – October 2025

0
The review provides available information on the inspection of...

Nanolek Launches Russia’s First Full-Cycle Production of Human Papillomavirus (HPV) Vaccine

0
The biopharmaceutical company Nanolek, with the support of the...

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026